Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo plans to launch private-label Aleve in early 1997, Tagamet HB in June 1998.

This article was originally published in The Tan Sheet

Executive Summary

PERRIGO PLANNING PRIVATE LABEL OTC NAPROXEN SODIUM FOR EARLY 1997 LAUNCH, VP-Business and Product Development Carl Johnson told the Dillon Read Generic Drug & Drug Delivery Conference in New York City May 7. "We have successfully completed a biostudy" on an equivalent Aleve product, Johnson reported. "We have filed our ANDA and it has been accepted, and we're very confident that we will be in a position to ship this product when the marketing exclusivity period expires early in 1997."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085384

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel